<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-1-4899-7448-8</journal-id><journal-id journal-id-type="doi">10.1007/978-1-4899-7448-8</journal-id><journal-id journal-id-type="nlm-ta">Viral Infections of Humans</journal-id><journal-title-group><journal-title>Viral Infections of Humans</journal-title><journal-subtitle>Epidemiology and Control</journal-subtitle></journal-title-group><isbn publication-format="print">978-1-4899-7447-1</isbn><isbn publication-format="electronic">978-1-4899-7448-8</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7119994</article-id><article-id pub-id-type="publisher-id">5</article-id><article-id pub-id-type="doi">10.1007/978-1-4899-7448-8_5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Viral Dynamics and Mathematical Models</article-title></title-group><contrib-group content-type="book editors"><contrib contrib-type="editor"><name><surname>Kaslow</surname><given-names>Richard A.</given-names></name><address><phone>+1205975-8698</phone><fax>+1205934-8665</fax><email>Rkaslow@ms.soph.uab.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="editor"><name><surname>Stanberry</surname><given-names>Lawrence R.</given-names></name><address><phone>+1212-305-2934</phone><email>lrs2155@columbia.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="editor"><name><surname>Le Duc</surname><given-names>James W.</given-names></name><address><email>jwleduc@utmb.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.265892.2</institution-id><institution-id institution-id-type="ISNI">0000000106344187</institution-id><institution>Department of Epidemiology, </institution><institution>University of Alabama, Birmingham School of Public Health, </institution></institution-wrap>Birmingham, Alabama USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Departmant of Pediatrics, </institution><institution>Columbia University College of Physicians and Surgeons, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.176731.5</institution-id><institution-id institution-id-type="ISNI">0000000115479964</institution-id><institution>Department of Microbiology and Immunology, </institution><institution>University of Texas Medical Branch, </institution></institution-wrap>Galveston, Texas USA </aff></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Arinaminpathy</surname><given-names>Nimalan</given-names></name><degrees>DPhil</degrees><address><email>nim.pathy@imperial.ac.uk</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Metcalf</surname><given-names>Charlotte Jessica E.</given-names></name><degrees>PhD</degrees><address><email>cmetcalf@princeton.edu</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Grenfell</surname><given-names>Bryan T.</given-names></name><degrees>PhD</degrees><address><email>grenfell@princeton.edu</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution-id institution-id-type="ISNI">0000000121138111</institution-id><institution>Department of Infectious Disease Epidemiology, </institution><institution>Imperial College London, </institution></institution-wrap>London, UK </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.16750.35</institution-id><institution-id institution-id-type="ISNI">0000000120975006</institution-id><institution>Department of Ecology and Evolutionary Biology and the Woodrow Wilson School, </institution><institution>Princeton University, </institution></institution-wrap>Princeton, NJ USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.16750.35</institution-id><institution-id institution-id-type="ISNI">0000000120975006</institution-id><institution>Department of Ecology and Evolutionary Biology and, </institution><institution>Woodrow Wilson School of Public and International Affairs, Princeton University, </institution></institution-wrap>211 Eno Hall, Princeton, NJ 08544 USA </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>2</month><year>2014</year></pub-date><fpage>81</fpage><lpage>96</lpage><permissions><copyright-statement>&#x000a9; Springer Science+Business Media New York 2014</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p>Mathematical tools have been widely applied in understanding the dynamics and control of viral infections. Here we present some fundamental aspects of infection dynamics, starting with acute immunising infections as a case study for herd immunity and other important factors in the spread and control of infection. We then discuss the dynamics of infections with more complex life histories, including chronic infections, and those showing evolution for immune escape. We conclude with a discussion of important gaps in our current understanding of viral dynamics, along with future research needs.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Human Immunodeficiency Virus</kwd><kwd>Host Population</kwd><kwd>Immune Escape</kwd><kwd>Herd Immunity</kwd><kwd>Severe Acute Respiratory Syndrome</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media New York 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>The application of mathematics to explore the dynamics and control of viral infections has a long history, which predates its application in many other fields of biology, as well as the germ theory itself [<xref ref-type="bibr" rid="CR1">1</xref>]. A particularly fruitful area for development has been the dynamics of acute immunizing infections, with their relatively simple natural history and rich notification time series [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. The last three decades have seen a considerable upsurge in the use of mathematical and computational models to explore the dynamics and control of a wide range of viral infections. This phase arose initially from developments in ecological population dynamics [<xref ref-type="bibr" rid="CR4">4</xref>]; it was then greatly accelerated, both by the explosion in computational power and by the emergence of human immunodeficiency virus (HIV) infection, severe acute respiratory syndrome (SARS), and other potential pandemic threats [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p>In this chapter, we review basic concepts in infection dynamics and control, via a synthesis of epidemic models and data. We begin with acute immunizing infections, focusing on measles as a case study of the impact of herd immunity and other determinants of epidemic dynamics. We then extend the discussion to dynamical modeling applications to a range of other acute and chronic viruses, with a variety of more complex life histories. After a brief discussion of models for the within-host dynamics of viruses, we conclude with suggestions for gaps in knowledge and future research needs.</p></sec><sec id="Sec2"><title>Dynamics of Acute Immunizing Infections</title><sec id="Sec3"><title>Observed Epidemic Patterns</title><p>Acute immunizing infections typically generate recurrent epidemics in large communities. We illustrate these patterns with the best documented case &#x02013; the dynamics of measles in large cities in England and Wales [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Figure <xref rid="Fig1" ref-type="fig">5.1a</xref> shows the time series of raw weekly notifications for measles in London from 1944 (shortly after measles cases became notifiable) to 1994.
<fig id="Fig1"><label>Fig. 5.1</label><caption><p>(<bold>a</bold>) Observed spatiotemporal dynamics of measles in England and Wales, showing weekly aggregate time series of notifications for London. (<bold>b</bold>) Basic flows of individuals captured by the SEIR model. (<bold>c</bold>) Schematic time series of numbers of susceptible individuals, arising from flows in panel <bold>b</bold>, and in particular following the introduction of one infectious individual into a wholly susceptible population; the effect of birth rate on susceptibility is ignored. (<bold>d</bold>) Corresponding dynamics for the proportion of the population susceptible (line marked &#x0201c;<italic>S</italic>&#x0201d;) and the proportion infected (line marked &#x0201c;<italic>I</italic>&#x0201d;) (<bold>b</bold>, <bold>d</bold>: Taken from Fig. 2, Grenfell [<xref ref-type="bibr" rid="CR6">6</xref>]. Figure found on p. 38)</p></caption><graphic xlink:href="100769_5_En_5_Fig1_HTML" id="MO1"/></fig>
</p><p>These data indicate three fairly distinctive dynamical eras:<list list-type="bullet"><list-item><p>1944&#x02013;1950: Principally annual epidemics.</p></list-item><list-item><p>1950s&#x02013;1960s: Regular, mainly biennial epidemic cycles, with intervening small annual peaks &#x02013; incidence rates are markedly <italic>seasonal</italic> (Sect. <xref rid="Sec6" ref-type="sec">2.4</xref>).</p></list-item><list-item><p>1970s onwards: The vaccine era brought declining incidence, with increasing irregular, lower-amplitude epidemic cycles. By the end of the series shown in this figure, cases became very sporadic, with increasing levels of mis-notification of clinically identified cases [<xref ref-type="bibr" rid="CR7">7</xref>].</p></list-item></list>
</p><p>As well as these fluctuations in individual large cities, there are also rich dynamical patterns in the <italic>spatial spread</italic> of epidemics among large and small communities (Sect. <xref rid="Sec10" ref-type="sec">4</xref>). Regional and temporal demographic variations, especially in <italic>birth rate</italic>, can also markedly influence dynamics (Sect. <xref rid="Sec6" ref-type="sec">2.4</xref>).</p></sec><sec id="Sec4"><title>Epidemic Dynamics: The SEIR Model</title><p>The striking epidemic patterns of acute immunizing infections are particularly well documented for widely notifiable infections such as measles. The process of explaining these cycles, as well as that of addressing associated public health issues, has spawned an extensive analytical literature, spanning public health epidemiology, theoretical biology, and population dynamics [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>]. The key conceptual tool has been a family of compartmental dynamical models, based on the SIR (susceptible-infected-recovered) paradigm [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. As described below, the SIR family successfully captures many key features of the epidemiological dynamics and control of viral infections.</p><p>The basic SIR formulation embodies the dynamics of immunizing infections. Because viruses reproduce rapidly in the host, we ignore within-host kinetics in the simplest SIR models (but see Sect. <xref rid="Sec23" ref-type="sec">8</xref>); depending on model details, this leads to a compartmentalization of the host population between (as yet uninfected) susceptible individuals, infected, recovered, and other classes. An initial taxonomic split here is between the SIR model (which crudely assumes that all infected individuals can pass on infection) and the SEIR (susceptible, exposed, infected, recovered) model, which adds an &#x0201c;exposed&#x0201d; (infected but not yet infectious) class [<xref ref-type="bibr" rid="CR4">4</xref>]. SIR and SEIR models have qualitatively very similar dynamics [<xref ref-type="bibr" rid="CR13">13</xref>]; however, we describe the latter with its more realistic depiction of viral incubation. The basic SEIR model, illustrated in Fig. <xref rid="Fig1" ref-type="fig">5.1b</xref>, reflects the following set of biological assumptions; we use measles as the classic acute exemplar here [<xref ref-type="bibr" rid="CR14">14</xref>]. After a few months of maternally derived passive immunity, infants enter the virus-na&#x000ef;ve &#x0201c;susceptible&#x0201d; (S) class; susceptibles can then become infected by close contact with infectious individuals (generally via respiratory aerosol for measles). Infection moves individuals into the &#x0201c;exposed&#x0201d; (E) class, where they incubate but do not transmit the infection for around a week; this leads to the infectious (I) class, where virus is shed, again for approximately a week, after which individuals enter the recovered state (R). In the basic SEIR model, recovered individuals are assumed to be immune for life, both to clinical disease and to retransmitting the infection. However, subclinical infection (and hence boosting of immunity [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]) is in principle possible. The lifelong sterilizing immunity induced by such an infection also makes this an excellent potential vaccine candidate [<xref ref-type="bibr" rid="CR4">4</xref>]. For the SEIR model, vaccination is at its simplest assumed to be delivered to a proportion <italic>p</italic> of infants at the end of the maternal immunity period (i.e., near the effective &#x0201c;birth&#x0201d; of susceptibles). For individuals who seroconvert, immunity is then often assumed to be lifelong, moving susceptibles into the recovered class (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>). There is also a considerable literature exploring more operationally realistic age distributions and immunogenic characteristics of vaccines in specific cases [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec5"><title>Herd Immunity and the Impact of Vaccination</title><p>We can lay bare much of the dynamical behavior of immunizing epidemics by considering the case of the &#x0201c;simple&#x0201d; epidemic (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>, <xref rid="Fig1" ref-type="fig">d</xref>), in which the outbreak occurs sufficiently rapidly to ignore processes of host birth and death. The talismanic quantity here is the basic reproduction number (or ratio) of infection, <italic>R</italic>
<sub>0</sub> [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. At its simplest, <italic>R</italic>
<sub>0</sub> is defined as the total number of secondary cases caused by an infectious individual when introduced into a well-mixed fully susceptible population. To illustrate the ensuing dynamics, consider an epidemic of infection with <italic>R</italic>
<sub>0</sub>&#x02009;&#x0003e;&#x02009;0. Since each case initially causes <italic>R</italic>
<sub>0</sub> secondary infections, the epidemic increases more or less exponentially over the first few infectious generations (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>). However, these dynamics rapidly deplete the susceptible pool. This brings us to the other key parameter of epidemic spread: the <italic>effective</italic> reproduction number, defined as <italic>R</italic>&#x02009;=&#x02009;[<italic>S</italic>/<italic>N</italic>]<italic>R</italic>
<sub>0</sub>. Here, <italic>S</italic>/<italic>N</italic> is the proportion of susceptibles in the population and <italic>R</italic> is the realized value of <italic>R</italic>
<sub>0</sub> as the epidemic develops [<xref ref-type="bibr" rid="CR4">4</xref>]. Since S declines over the course of the epidemic (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>), so does <italic>R</italic> (Fig. <xref rid="Fig1" ref-type="fig">5.1d</xref>).</p><p>This progressive decline in secondary infection rates through the epidemic is a manifestation of the key epidemiological process of <italic>herd immunity</italic> [<xref ref-type="bibr" rid="CR18">18</xref>] &#x02013; increasing natural immunity of the population that indirectly protects the remaining susceptibles from infection. Eventually, the effective reproduction ratio declines through unity (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>) as population immunity increases; this corresponds to the herd immunity threshold, above which the epidemic will always decline, even if reintroduced to a closed population. This threshold is thus also a key aim of vaccination campaigns [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Remembering that <italic>R</italic>&#x02009;=&#x02009;[<italic>S</italic>/<italic>N</italic>]<italic>R</italic>
<sub>0</sub>, the associated susceptible proportion at the herd immunity threshold (<italic>R</italic>&#x02009;=&#x02009;1) becomes <italic>s</italic>
<sub>c</sub>&#x02009;=&#x02009;1/<italic>R</italic>
<sub>0</sub> (Fig. <xref rid="Fig1" ref-type="fig">5.1c</xref>); thus, immunizing at a level above <italic>p</italic>
<sub>c</sub>&#x02009;=&#x02009;1&#x02009;&#x02212;&#x02009;<italic>s</italic>
<sub>c</sub>&#x02009;=&#x02009;1&#x02009;&#x02212;&#x02009;1/<italic>R</italic>
<sub>0</sub> will eliminate local transmission. As described below, these calculations have been refined considerably to allow for heterogeneities in transmission with age, space, and other characteristics (Sects. <xref rid="Sec9" ref-type="sec">3</xref>, <xref rid="Sec10" ref-type="sec">4</xref>, and <xref rid="Sec11" ref-type="sec">5</xref>). Nonetheless, our simple expression for <italic>p</italic>
<sub>c</sub> is an extremely useful metaphor for epidemic control: (1) because of indirect protection, not everyone needs to be vaccinated to eliminate transmission (corresponding to <italic>p</italic>
<sub>c</sub>&#x02009;&#x0003c;&#x02009;1) and (2) the effort required to increase this level of immunization increases with transmission rates. The latter point is made clear by a simple plot of <italic>p</italic>
<sub>c</sub> against <italic>R</italic>
<sub>0</sub> (Fig. <xref rid="Fig2" ref-type="fig">5.2</xref>); more transmissible immunizing infections such as measles are harder to control than less transmissible agents such as smallpox. However, this refers to &#x0201c;random&#x0201d; mass vaccination; more targeted strategies such as ring vaccination coupled to active surveillance can promote elimination even below <italic>p</italic>
<sub>c</sub>, given (as with smallpox elimination [<xref ref-type="bibr" rid="CR19">19</xref>]) the right biological characteristics and logistics. Partial immunity and other characteristics of the population can complicate the picture still further (see Sect. <xref rid="Sec13" ref-type="sec">5.2</xref> below). Nonetheless, the metaphor that more transmissibility necessitates a stronger vaccination effort remains.
<fig id="Fig2"><label>Fig. 5.2</label><caption><p>The critical vaccination threshold (<italic>p</italic>
<sub>c</sub>) and its dependence on the basic reproduction number, <italic>R</italic>
<sub>0</sub>. In the region above the <italic>blue line</italic>, vaccination succeeds in local elimination of infection. Even in the region below the line, however, vaccination can substantially reduce overall transmission</p></caption><graphic xlink:href="100769_5_En_5_Fig2_HTML" id="MO2"/></fig>
</p></sec><sec id="Sec6"><title>Seasonal Transmission and Recurrent Epidemic Dynamics</title><sec id="Sec7"><title>Observed Epidemic Patterns in Developed Countries</title><p>In the simplest analysis of an immunizing infection (Sect. <xref rid="Sec4" ref-type="sec">2.2</xref>), sustained cycles of infection will disappear, and the infected proportion in the population will settle to a constant level (Fig. <xref rid="Fig3" ref-type="fig">5.3a</xref>). The question of what maintains the recurrent epidemics [<xref ref-type="bibr" rid="CR9">9</xref>] generally observed for immunizing childhood infections (e.g., Fig. <xref rid="Fig1" ref-type="fig">5.1</xref>) drove researchers to seek the key aspect of biological realism missing from the simplest SEIR model. For measles in England and Wales, seasonal variation in transmission driven by increased contact rates of children when schools were in session rapidly emerged as a possible candidate [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] and has since received considerable empirical support [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Stochastic fluctuations in incidence could in principle also contribute to the maintenance of cycles [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]; however, for measles, the predominant driver is seasonality in transmission [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Birth rate may modulate the periodicity of recurrent cycles driven by seasonality through its role in determining the rate of susceptible replenishment [<xref ref-type="bibr" rid="CR24">24</xref>]. For example, for most of the postwar pre-vaccination era in London, seasonality generated sustained cycles by resonating with the biennial epidemic tendency of measles dynamics. However, during the postwar baby boom, births achieved sufficient levels to shift measles dynamics into annual cycles (Fig. <xref rid="Fig4" ref-type="fig">5.4</xref>).
<fig id="Fig3"><label>Fig. 5.3</label><caption><p>(<bold>a</bold>) Simulated SEIR dynamics for measles with a birth rate, but in the absence of seasonal forcing of transmission rate; for full model specification and parameters, see Grenfell and Bolker [<xref ref-type="bibr" rid="CR20">20</xref>]. (<bold>b</bold>) Same model, with sinusoidal forcing of the infection as shown (forcing amplitude set to 0.2; Grenfell and Bolker [<xref ref-type="bibr" rid="CR20">20</xref>]). The green trajectory shows the joint dynamics of susceptible and infectious densities through time; area plots show the dynamics of infectious and susceptible individuals (Taken from Fig. 3 in above book chapter, found on p.39)</p></caption><graphic xlink:href="100769_5_En_5_Fig3_HTML" id="MO3"/></fig>
<fig id="Fig4"><label>Fig. 5.4</label><caption><p>(<bold>a</bold>) Observed pre-vaccinations measles dynamics for London (<italic>red circles</italic>), corrected for under-reporting, along with predictions of an autoregressive time series version of the SEIR model, starting at the observed initial density of cases and susceptibles (for more details, see [<xref ref-type="bibr" rid="CR126">126</xref>]) (<bold>b</bold>) Birth rates accompanying the dynamics in panel (<bold>a</bold>) (Taken from Fig. 4 in above book chapter, found on p. 41)</p></caption><graphic xlink:href="100769_5_En_5_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec8"><title>Epidemic Dynamics in Developing Countries</title><p>It was realized early that seasonality could also result in more complex dynamics, including chaotic fluctuations, that is, very irregular dynamics with little long-term predictability. Contexts with both high and low birth rates (and both high and low transmission since birth rates and transmission act dynamically in very similar ways for immunizing infections [<xref ref-type="bibr" rid="CR24">24</xref>]) can promote complex dynamics via coexisting attractors. Until recently, it was thought that chaotic measles dynamics were not likely to be observed [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], since observed seasonality in transmission was not strong enough to drive the associated violent epidemics. However, recent analyses of measles in Niger revealed very strong seasonality (driven by movement in and out of cities linked to rainfall); this, combined with high transmission rates and the highest birth rate in the world, results in irregular outbreaks consistent with expectations of chaos (Fig. <xref rid="Fig5" ref-type="fig">5.5</xref>). Erratic boom and bust outbreaks are expected to continue even as routine vaccination improves; and this suggests that high investment in reactive vaccination and surveillance is important, and pulsed vaccination approaches such as supplementary immunization activities could also play a helpful role in synchronizing dynamics [<xref ref-type="bibr" rid="CR26">26</xref>].
<fig id="Fig5"><label>Fig. 5.5</label><caption><p>Time series dynamics of measles outbreaks from Niger. (<bold>a</bold>) Mean number of reported measles cases per 10,000 nationwide in Niger from 1995 to 2004, and the mean monthly rainfall over the same time period (<italic>blue</italic>). Shaded regions give &#x000b1;2 standard deviations. <italic>Black curve</italic>, mean monthly cases of measles in Niamey from 1986 to 2005. <italic>Inset</italic> monthly measles time series from 1995 to 2004. (<bold>b</bold>) Weekly measles case reports from seven departments of Niger, 2001&#x02013;2005. <italic>Red asterisk</italic> Niamey. Each department is an aggregate of 3&#x02013;8 arrondissements. (<bold>c</bold>) Case reports per month for the city of Niamey from 1986 to 2005. The <italic>box</italic> indicates the time frame shown in (<bold>b</bold>). <italic>Black dots</italic> months with 0 reported cases (Taken from Fig. 1, Ferrari et al. [<xref ref-type="bibr" rid="CR26">26</xref>]; http://www.nature.com/nature/journal/v451/n7179/images/nature06509-f1.2.jpg)</p></caption><graphic xlink:href="100769_5_En_5_Fig5a_HTML" id="d29e898"/><graphic xlink:href="100769_5_En_5_Fig5b_HTML" id="d29e899"/></fig>
</p></sec></sec></sec><sec id="Sec9"><title>Age Structure, Demography, and Serological Profiles</title><p>The mean age at which individuals become infected by immunizing viral infection is generally lower for infections with higher rates of transmission or <italic>R</italic>
<sub>0</sub> (defined above). Intuitively, this occurs because the faster an immunizing virus is spreading through a population, the younger the age at which individuals are likely to be exposed to it. Host demography modulates this relationship, and higher birth rate countries with an <italic>R</italic>
<sub>0</sub> equivalent to that in lower birth rate countries will tend to have a lower average age of infection [<xref ref-type="bibr" rid="CR27">27</xref>]. Maternal immunity, or protection of children after birth by transfer of maternal antibodies, will also have an impact, increasing the average age of infection for children whose mothers have been exposed to infection. Since maternal antibodies rarely persist for much more than a year, this effect will be greatest for infections with very low average ages of infection [<xref ref-type="bibr" rid="CR4">4</xref>]. Beyond these broad descriptors, however, there is the added complication of possible relationships between age and probability of exposure to infection. Such relationships may arise for a variety of reasons. For example, only individuals beyond a certain age may work in areas where the disease is transmitted, or the disease may be only sexually transmitted. As a result, the force of infection, or probability that a susceptible individual will be infected, will show a distinct relationship with age.</p><p>For directly transmitted infections, like measles, mumps, rubella, and influenza, the age profile of the force of infection is determined by the rate at which individuals of different ages interact. There are two approaches to estimating this variation. The first is to use age profiles of seropositivity to infer the pattern of the force of infection and, from this, extrapolate to the pattern of contacts over age [<xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. The link between these age profiles and the force of infection over age can be made since once an individual has been infected, she/he can never be infected again. Therefore, to be immune at any age, the individual must have contracted the infection prior to that age. On a population level, cross-sectional seropositivity thus provides an indication of the total risk of infection for individuals up to a given age. (Longitudinal age-serological profiles can be even more powerful in quantifying epidemic risk [<xref ref-type="bibr" rid="CR32">32</xref>]).</p><p>The age profile of infection can be framed mathematically [<xref ref-type="bibr" rid="CR33">33</xref>], and parameters describing contacts between individuals of different ages inferred [<xref ref-type="bibr" rid="CR31">31</xref>]. The resulting estimated matrix of contacts over age is known as the Who-Acquires-Infection-from-Whom or WAIFW matrix. Alternatively, patterns of contacts between individuals can be directly measured [<xref ref-type="bibr" rid="CR34">34</xref>], for example, using diary studies (Fig. <xref rid="Fig6" ref-type="fig">5.6</xref>); and by combining this with the age profile of infection within the population, the force of infection over age can be inferred [<xref ref-type="bibr" rid="CR35">35</xref>].
<fig id="Fig6"><label>Fig. 5.6</label><caption><p>(<bold>a</bold>) Contact matrix (annual) estimated from serology profiles and incidence data using maximum likelihood approaches (Ref. [<xref ref-type="bibr" rid="CR30">30</xref>]), here showing a semi-assortative mixing matrix; (<bold>b</bold>) POLYMOD contact matrix (daily) obtained from diary studies showing records across all of Europe (Ref. [<xref ref-type="bibr" rid="CR34">34</xref>])</p></caption><graphic xlink:href="100769_5_En_5_Fig6_HTML" id="MO6"/></fig>
</p><p>The infection dynamics themselves may also influence the relationship between age and force of infection. If outbreaks are separated by long intervals during which little exposure occurs, individuals may remain susceptible for many years and thus contract the infection at a later age than might be predicted from the age profile of contacts alone [<xref ref-type="bibr" rid="CR36">36</xref>]. More subtly, detailed network analyses show that even within a single influenza outbreak, the burden of disease can cascade from children (where contacts are highest) to the less connected adults as immunity accumulates within the children, with implications for optimal vaccination distribution [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p>Understanding the processes underlying the average age of infection has a practical importance for any infection where the burden of disease shows an age profile. Rubella is a classic example. Infection during early childhood tends to be mild, but infection during pregnancy may result in birth of a child with congenital rubella syndrome, consisting of a range of birth defects (see Ref. [<xref ref-type="bibr" rid="CR38">38</xref>]). A realistically complex age structure of mixing, as detailed in empirical studies, may thus be of crucial importance in establishing the burden of disease [<xref ref-type="bibr" rid="CR39">39</xref>] but also how the burden of disease is likely to change as a result of vaccination.</p></sec><sec id="Sec10"><title>Spatial Dynamics</title><p>So far, we have assumed that deterministic, spatially homogeneous dynamics govern infectious disease outbreaks. In fact, epidemics often spread across a heterogeneous landscape of human cities, towns, or rural communities, and this spread depends partly on the links between those locations. This leads us to move from the <italic>deterministic</italic> SIR model described above to <italic>stochastic</italic> models, which account for the random nature of individual infection dynamics and demography &#x02013; for instance, individuals may or may not become infected with a given average probability, so that by chance, particularly in small populations, no new infections may occur, and the chain of transmission may be broken. During the troughs between epidemic outbreaks in smaller communities, incidence may fall to such low numbers that local extinction is likely.</p><p>Based on this observation, Bartlett [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR40">40</xref>] used analyses of epidemiological data and stochastic models to develop the notion of critical community size (CCS), or population size below which stochastic extinction is expected, which was further developed by Black [<xref ref-type="bibr" rid="CR41">41</xref>] in studies of measles persistence in insular populations. Bartlett demonstrated the existence of a CCS of around 300,000&#x02013;500,000 for measles in England and Wales. For measles to persist in locations with a population size smaller than this CCS, immigration of infected immigrants from elsewhere in the metapopulation is necessary. The result is that the spread of measles across England and Wales in the pre-vaccine era resembled traveling waves spreading out from London [<xref ref-type="bibr" rid="CR6">6</xref>], with a substantial epidemic lag in locations further away. The duration of the lag was also shaped by the size of the local populations. The duration of fade-outs following local extinction contains information on the degree to which a particular location is connected to the metapopulation as a whole [<xref ref-type="bibr" rid="CR42">42</xref>]. Generally, this points to larger places being more connected. More detailed parametric analyses tend to confirm this (e.g., the gravity model [<xref ref-type="bibr" rid="CR43">43</xref>]).</p><p>Similar processes may operate for immunizing or lethal infections in animal populations, with, for example, the spread of rabies through raccoon populations acting as an invasion wave structured by large landscape features such as rivers [<xref ref-type="bibr" rid="CR44">44</xref>]. For more complex human infections, features such as imperfect immunity (see Sect. <xref rid="Sec13" ref-type="sec">5.2</xref> below) will tend to shift the age class of hosts who disperse the infection. That shift may impact on the main mechanism of dispersal [<xref ref-type="bibr" rid="CR45">45</xref>] and move the scenario away from invasion into a locally coupled landscape to a more demographically driven dynamic [<xref ref-type="bibr" rid="CR46">46</xref>].</p></sec><sec id="Sec11"><title>Comparative Dynamics</title><p>So far, we have explored the epidemiological dynamics of acute, immunizing viral infections. Though the resulting dynamics are both important and fascinating from a dynamical perspective, the natural (life) history of most viral infections departs, in one way or another, from this simple case. We review these complexities, and their epidemiological and control implications, in succeeding Sections.</p><sec id="Sec12"><title>From Acute to Chronic</title><p>A dramatically different life history from the transient infection paradigm represented by measles is observed with infections that are much more persistent (even lifelong). This difference may be expressed in terms of infectious period in individual hosts [<xref ref-type="bibr" rid="CR4">4</xref>]. To illustrate how increasing infectious period alone modifies the violent epidemics of childhood infections, we retain the assumption of lifelong immunity of the SEIR model and vary the infectious period, from the roughly 1 week of measles to 10 years, corresponding to the approximate average pre-HAART treatment infectious period of HIV [<xref ref-type="bibr" rid="CR4">4</xref>].
<fig id="Fig7"><label>Fig. 5.7</label><caption><p>Numerical solutions of seasonally forced SEIR models (see Fig. <xref rid="Fig3" ref-type="fig">5.3b</xref>), showing changes in the dynamics of infection caused by increasing the infectious period (see <italic>color key</italic>) while maintaining the basic reproduction number of infection at a constant level. To simulate crudely the initial dynamics of a &#x0201c;novel&#x0201d; infection, the system starts by introducing 6 % infectives into a 20 % susceptible population (a real novel epidemic might be much more violent if everyone is susceptible). <italic>Inset</italic>: Comparing the &#x0201c;slow&#x0201d; dynamics generated by a 10-year infectious period with a (sketched) solution of an SIS model with much faster dynamics (Taken from Figure in Box 2, Grenfell and Harwood [<xref ref-type="bibr" rid="CR47">47</xref>])</p></caption><graphic xlink:href="100769_5_En_5_Fig7_HTML" id="MO7"/></fig>
</p><p>Figure <xref rid="Fig7" ref-type="fig">5.7</xref> explores this comparison, simulating an infection which invades a partly susceptible population (full details are given in Ref. [<xref ref-type="bibr" rid="CR6">6</xref>]; note that for clarity, the epidemic curves for 1- and 10-year infectious periods are raised above the curves for the more acute infections). Each simulation refers to a virus with a different infectious period. We assume that <italic>R</italic>
<sub>0</sub> is identical for each of these infections. <italic>R</italic>
<sub>0</sub> is roughly given by the product of mean <italic>per capita</italic> infection rate and infectious period; thus, to keep <italic>R</italic>
<sub>0</sub> constant:<list list-type="bullet"><list-item><p>A short infectious period implies a relatively high infection rate.</p></list-item><list-item><p>A longer infectious period requires a lower infection rate.</p></list-item></list>
</p><p>This assumption imposes a simple evolutionary constraint on our set of model pathogens in Fig. <xref rid="Fig7" ref-type="fig">5.7</xref>, in that fitness (roughly equating to <italic>R</italic>
<sub>0</sub>) is kept constant as we increase the infectious period. Figure <xref rid="Fig7" ref-type="fig">5.7</xref> indicates, first, that increasing the infectious period reduces, and eventually eliminates, the tendency for cyclical epidemics [<xref ref-type="bibr" rid="CR48">48</xref>]; essentially, a longer infectious period &#x0201c;fills in the troughs&#x0201d; following major epidemics. As infectious period increases, we therefore see a transition from seasonally driven biennial epidemics (at the measles extreme of a 1-week infectious period) to low-amplitude annual epidemics (at 1 month). For longer infectious periods (1 year), we see slowly evolving epidemics with little seasonal activity and a modest post-epidemic overshoot. Finally, for a 10-year infectious period, we see a smooth slow epidemic, with an essentially &#x0201c;logistic&#x0201d; rise to a stable endemic plateau of incidence. Though crude, this exercise captures the essential dynamical transmission from the violent epidemics of acute infections to the much smoother and slower epidemic invasion of HIV [<xref ref-type="bibr" rid="CR4">4</xref>]. Note that the seasonal variation in infection rate is assumed similar for the &#x0201c;measles&#x0201d; and &#x0201c;HIV&#x0201d; cases; however, the latter completely eliminates associated seasonal fluctuations in incidence due to the smoothing effect of prolonged infectious carriage.</p><p>Figure <xref rid="Fig7" ref-type="fig">5.7</xref> also illustrates a second major dynamical impact arising from the trade-off of increased infectious period against lowered infection rate. &#x0201c;Fast&#x0201d; infections are much more prey to local stochastic extinction in the deep troughs between epidemics (Sect. <xref rid="Sec6" ref-type="sec">2.4</xref>) than the much more endemic incidence promoted by longer infectious period. On the other hand, acute immunizing infections can invade populations much more quickly than chronic infections for the same <italic>R</italic>
<sub>0</sub> (Note that very imperfect immunity (corresponding to &#x02018;SIS&#x02019; dynamics) could generate &#x02018;fast&#x02019; invasion even for relatively chronic infections (Figure <xref rid="Fig7" ref-type="fig">5.7</xref>, inset), because of the increased supply of susceptible individuals (Sect. <xref rid="Sec13" ref-type="sec">5.2</xref>)). Note that, despite these great variations in dynamics, the assumption of a common <italic>R</italic>
<sub>0</sub> means that the herd immunity threshold for elimination of infection is the same across this range of behaviors Sect. (<xref rid="Sec5" ref-type="sec">2.3</xref>).</p></sec><sec id="Sec13"><title>Departures from the SEIR Paradigm</title><p>We have seen that the SEIR framework (Fig. <xref rid="Fig1" ref-type="fig">5.1b</xref>) can be a powerful tool for capturing the dynamics of perfectly immunizing infections such as measles. With its various refinements to incorporate structure in the host population (such as age and spatial distribution), it yields a rich variety of dynamical behavior (Fig. <xref rid="Fig7" ref-type="fig">5.7</xref>). Given the range of immunological complexities and different viral life histories, however, it is clear that SEIR dynamics are only part of the story. In such cases, it is often possible to adapt Fig. <xref rid="Fig1" ref-type="fig">5.1b</xref> to more faithfully reflect such important biological complexities.
<fig id="Fig8"><label>Fig. 5.8</label><caption><p>Examples for extensions of the basic SEIR model (Fig. <xref rid="Fig1" ref-type="fig">5.1b</xref>). (<bold>a</bold>) Waning immunity can be represented by allowing individuals to return from recovered (<italic>R</italic>) to susceptible (<italic>S</italic>) status at a given rate. (<bold>b</bold>) If acquired immunity affords clinical but not sterilizing (transmission-blocking) protection, then additional SEIR stages may be incorporated to capture the corresponding effects on transmission dynamics. (<bold>c</bold>) An example of population heterogeneity, distinguishing &#x0201c;acute&#x0201d; cases (<italic>I</italic>
<sub>A</sub>) from &#x0201c;carriers&#x0201d; (<italic>I</italic>
<sub>C</sub>), the latter recovering at a slower rate than the former</p></caption><graphic xlink:href="100769_5_En_5_Fig8_HTML" id="MO8"/></fig>
</p><sec id="Sec14"><title>Waning Immunity</title><p>Many viruses are capable of reinfecting a host. This may be due to the waning of host immunity over time, as with respiratory syncytial virus (RSV) [<xref ref-type="bibr" rid="CR49">49</xref>], or due to viral evolution for immune escape (e.g., with norovirus [<xref ref-type="bibr" rid="CR50">50</xref>] and influenza) [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]: see Sect. <xref rid="Sec18" ref-type="sec">6</xref> for a more in-depth treatment of the latter. In either case, the overall dynamical effect is for recovered, immune individuals to eventually reenter the susceptible pool, as illustrated by Fig. <xref rid="Fig8" ref-type="fig">5.8a</xref>.</p><p>Where such waning of immunity is appreciable, the implications for vaccination can be profound. As the susceptible pool is replenished not only by births but also by previously immune individuals, the critical vaccination threshold (Sect. <xref rid="Sec5" ref-type="sec">2.3</xref>) is raised, making it more difficult to control the spread of infection. For this reason, vaccination against many imperfectly immunizing infections is aimed at direct protection of those receiving vaccine, rather than at raising indirect protection.</p></sec><sec id="Sec15"><title>Partial Immunity</title><p>So far, the models we have considered assume that immune individuals have solid, transmission-blocking immunity, even if this should wane through time. In reality, however, it is common for immunity to be clinically protective (i.e., against symptomatic disease) but only partially protective from infection. This applies, for example, in the case of rotavirus, the leading cause of severe diarrhea in infants worldwide [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Figure <xref rid="Fig8" ref-type="fig">5.8b</xref> illustrates a model structure developed to capture these dynamics [<xref ref-type="bibr" rid="CR46">46</xref>].</p></sec><sec id="Sec16"><title>Host Heterogeneity in Transmission</title><p>Recalling the qualitative differences between the dynamics of acute and chronic infections (Fig. <xref rid="Fig7" ref-type="fig">5.7</xref>), some viruses show a &#x0201c;mixed&#x0201d; character on the host population level: while some individuals clear infection relatively quickly, others may continue to harbor the virus as &#x0201c;carriers,&#x0201d; either in a latent phase or in a chronic infectious state, for a longer period. An example is hepatitis B, in which 5&#x02013;10 % of adult patients show chronic infection. As illustrated in Fig. <xref rid="Fig8" ref-type="fig">5.8c</xref>, this can be represented mathematically by identifying two infectious classes: one acute and the other chronic.</p><p>Such factors can have implications for the dynamics and persistence of infections in a population [<xref ref-type="bibr" rid="CR55">55</xref>]. In particular, where a disease shows epidemic cycles, facing the possibility of local extinction in the epidemic troughs, the presence of a small number of carrier hosts can facilitate viral persistence in the population, through these troughs. For example, in some cases infection with varicella zoster virus can be followed decades later by infectious shingles, an occurrence which could maintain the virus in small populations [<xref ref-type="bibr" rid="CR56">56</xref>].</p></sec><sec id="Sec17"><title>Complex Viral Strain Interactions</title><p>Strain structure, vector dynamics, and seasonality in transmission offer yet more complexities, as in the example of dengue [<xref ref-type="bibr" rid="CR57">57</xref>]. Spread by <italic>Aedes</italic> mosquitoes, dengue has shown a significant emergence worldwide in the last 50 years.</p><p>Dengue dynamics are notable for the global circulation of four distinct serotypes (see Fig. <xref rid="Fig9" ref-type="fig">5.9a</xref>). Notably, prior immunity to a given serotype can elevate the risk of severe disease from subsequent infection by a different serotype [<xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref>]. It has been proposed that this arises from antibody-dependent enhancement (ADE) between different serotypes [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>], and modeling studies suggest that ADE could play an important role in shaping the epidemiological and strain dynamics of dengue, on the host population level [<xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref>].</p><p>However, there are also indications of a short period of cross-protective immunity (i.e., against all serotypes) for 2&#x02013;9 months following infection [<xref ref-type="bibr" rid="CR68">68</xref>], potentially mediating some degree of competition between serotypes. Several studies have addressed the dynamical implications of interactions between ADE and such immunity [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Dengue dynamics are therefore complex and multifactorial: an understanding of these effects is important in understanding the potential for unexpected effects from transmission-reducing interventions [<xref ref-type="bibr" rid="CR71">71</xref>].
<fig id="Fig9"><label>Fig. 5.9</label><caption><p>(<bold>a</bold>) A diversity of viral diversity: examples of major human infections showing different patterns of evolution (Taken from (Ref. [<xref ref-type="bibr" rid="CR58">58</xref>]), and references therein; Adapted from Fig. 1, Grenfell et al. [<xref ref-type="bibr" rid="CR58">58</xref>]) (<bold>b</bold>) Schematic illustration of the &#x0201c;epochal evolution&#x0201d; model, which seeks to explain notable features in the phylogeny of human influenza A (panel <bold>a</bold>, rightmost phylogeny) (Taken from figure in van Nimwegen [<xref ref-type="bibr" rid="CR59">59</xref>])</p></caption><graphic xlink:href="100769_5_En_5_Fig9_HTML" id="MO9"/></fig>
</p></sec></sec></sec><sec id="Sec18"><title>Dynamics and Evolution of Immune Escape</title><p>Had viruses been discovered by the time that Darwin proposed &#x0201c;descent with modification&#x0201d; in the mid-nineteenth century, they may quickly have been recognized as fine examples of evolution in action. Indeed, today there is wide acknowledgment of the inextricable role that evolution plays in viral dynamics [<xref ref-type="bibr" rid="CR58">58</xref>] and in the control of many different viral infections. RNA viruses in particular, lacking the replication fidelity of a DNA genome, are capable of considerable mutation rates [<xref ref-type="bibr" rid="CR72">72</xref>]. In the presence of host immunity, natural selection will favor those mutants most capable of evading immunity while still being capable of spreading between hosts.</p><p>As a result of these high mutation rates, population-level evolutionary patterns that can arise are quite diverse. Figure <xref rid="Fig9" ref-type="fig">5.9a</xref> illustrates how some infections, such as HIV, show significant population-level diversity [<xref ref-type="bibr" rid="CR73">73</xref>], while others, notably seasonal influenza A, exhibit a markedly different pattern, with a &#x0201c;trunk-like&#x0201d; phylogeny on the population level [<xref ref-type="bibr" rid="CR74">74</xref>].</p><p>The case study of influenza demonstrates not only interesting evolutionary patterns but also the following important features:
<list list-type="simple"><list-item><label>(i)</label><p>The challenges that evolution can pose for infection control</p></list-item><list-item><label>(ii)</label><p>The complex interplay, across a range of physical scales, between the evolution of a pathogen and its success in spreading in a host population</p></list-item><list-item><label>(iii)</label><p>The many outstanding questions that remain, in understanding how viruses adapt to continue reinfecting their hosts</p></list-item></list>
</p><p>In what follows, we explore both within-host and population-level aspects of influenza evolution, with an emphasis on seasonal (interpandemic) influenza. We then set out the prevailing paradigms that seek to explain how these patterns arise, through complex interactions between viral evolution and epidemiology.</p><sec id="Sec19"><title>Immune Escape and Herd Immunity</title><p>Classic theoretical principles [<xref ref-type="bibr" rid="CR4">4</xref>] provide a useful framework in which to think about viral evolution, where &#x0201c;evolutionary fitness&#x0201d; is determined ultimately by the capacity for transmission in a given host population. Recall from Sect. <xref rid="Sec5" ref-type="sec">2.3</xref> that in the presence of prior immunity in the population, the effective reproduction number, <italic>R</italic>, serves as a compact measure of transmission potential. Vaccination aims to lower <italic>R</italic> through reducing the number susceptible in the population; however, evolving pathogens introduce the complexity of countering this effect, by evading immunity and thus acting to restore <italic>R</italic>. Note the combination of immune escape and transmissibility encapsulated in <italic>R</italic>. In particular, on the scale of the host population and with a given level of existing immunity, the escape mutant with the greatest evolutionary fitness is that which maximizes <italic>R</italic> [<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec><sec id="Sec20"><title>Molecular Aspects of Viral Evolution</title><p>As discussed in 10.1007/978-1-4899-7448-8_21, the influenza surface protein hemagglutinin (HA) is a key immune target, with anti-HA antibodies capable of offering sterilizing immunity, that is, the potential to block host infection altogether. Indeed, raising such immunity is a central function of current influenza vaccines. However, HA is also the most variable viral component, continually under selective pressure to escape antibody binding [<xref ref-type="bibr" rid="CR51">51</xref>]. For these reasons, while influenza evolution is by no means limited to HA, this viral component has attracted the most attention.</p><p>An important mechanism of immune escape is through conformational changes of HA epitopes to abrogate antibody binding, without compromising the ability of the virus to attach to host cells [<xref ref-type="bibr" rid="CR75">75</xref>]. More recently, however, results from mouse experiments suggest that escape mutants can also acquire increased viral avidity for host cells [<xref ref-type="bibr" rid="CR76">76</xref>]. Another potential immune escape strategy [<xref ref-type="bibr" rid="CR77">77</xref>] is glycosylation, or the attachment of oligosaccharides to the HA molecule, to occlude epitopes from antibody binding. Such strategies are not without potential functional costs for replication [<xref ref-type="bibr" rid="CR78">78</xref>], and yet there are indications that human influenza A/H3N2 has been accumulating glycosylation since its introduction into the human population in 1968 [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>].</p></sec><sec id="Sec21"><title>Population-Level Manifestations of HA Evolution</title><p>On a genetic level, the evolutionary pattern for influenza HA (Fig. <xref rid="Fig9" ref-type="fig">5.9a</xref>), showing serial replacement of strains through time, is often characterized as &#x0201c;drift.&#x0201d; The limited standing diversity, or &#x0201c;trunk-like&#x0201d; phylogeny, is especially paradoxical in light of the relatively high mutation rate of influenza A, where instead several lineages might have been expected to emerge and coexist in the population.</p><p>Moreover, how do such <italic>genetic</italic> patterns translate to <italic>antigenic</italic> properties, that is, viral interaction with anti-HA antibodies? In 2004, new techniques allowed a characterization of the antigenic evolution of the influenza subtype H3N2 [<xref ref-type="bibr" rid="CR74">74</xref>] during the years since its introduction into humans in 1968. The resulting pattern is characterized by &#x0201c;punctuations&#x0201d; in antigenic evolution, occurring roughly every 2&#x02013;8 years, in contrast with the more gradual pattern of genetic change shown in Fig. <xref rid="Fig9" ref-type="fig">5.9a</xref>. These punctuations have great importance for public health, often necessitating major reformulation of current, HA-based vaccines [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p>Two prevailing paradigms explaining these important phenomena, on both the genetic and antigenic levels, are the <italic>epochal evolution</italic> model [<xref ref-type="bibr" rid="CR82">82</xref>] and that of <italic>strain-transcending immunity</italic> [<xref ref-type="bibr" rid="CR83">83</xref>]<italic>.</italic> Both may be considered &#x0201c;phylodynamic&#x0201d; models [<xref ref-type="bibr" rid="CR58">58</xref>], in the sense of aiming to capture the complex interactions between viral immune escape, viral population genetics, and epidemiology.</p><p>The picture of &#x0201c;strain-transcending immunity&#x0201d; [<xref ref-type="bibr" rid="CR83">83</xref>] invokes a temporary mode of immunity, which immediately follows recovery from infection and protects the individual against infection by all influenza strains. Such broad immunity is postulated to arise, for example, either from T cells or from innate immunity [<xref ref-type="bibr" rid="CR83">83</xref>]. Over the course of months, this broad immunity gives way to more long-lived, more narrowly acting immunity that is specific to the immunizing strain. On the population level, a key dynamical effect of such immunity structure is to impose population-level constraints on viral diversity, sufficiently strong to maintain a single dominant lineage through time.</p><p>The epochal evolution model [<xref ref-type="bibr" rid="CR82">82</xref>] provides an alternative view. It builds on the proposal by Kimura in 1968 [<xref ref-type="bibr" rid="CR84">84</xref>] that many amino acid substitutions in nature do not alter evolutionary fitness and are thus <italic>phenotypically neutral</italic>. If influenza HA evolution can be thought of as tracing a series of paths through a space of genotypes, the epochal evolution model proposes that, in phenotypic terms, such a space has a modular structure (Fig. <xref rid="Fig9" ref-type="fig">5.9b</xref>) in which each &#x0201c;module&#x0201d; is a group of genotypes sharing the same antigenic phenotype and a transition between modules corresponds to the observed antigenic &#x0201c;jumps.&#x0201d; In particular, HA evolution diffuses through the local genotype space, accumulating neutral substitutions and thus genotypic diversity, over several years. Ultimately, a single strain accumulates the substitutions required to transition to a new antigenic phenotype. At this point, the emergent strain &#x02013; owing to its antigenic novelty &#x02013; causes a peak in infection and undergoes a selective sweep in the host population, to the exclusion of other strains. Such an event thus acts to periodically control antigenic diversity, maintaining the &#x0201c;trunk-like&#x0201d; shape of the influenza phylogeny.</p><p>Alongside these two prevailing paradigms of influenza evolution, yet another model [<xref ref-type="bibr" rid="CR85">85</xref>] proposes that observed strains are drawn from a limited set of antigenic types, with their selection dependent on niches in host population immunity. While each of these models succeeds in capturing important features of influenza dynamics, they also highlight important gaps in our understanding of viral evolution and how to manage it.</p></sec></sec><sec id="Sec22"><title>Coevolution and the Evolution of Virulence</title><p>The degree to which viruses harm hosts varies considerably. Both within and between virus species, some variants may barely affect hosts at all, while others have significant health impacts, up to and including host mortality [<xref ref-type="bibr" rid="CR86">86</xref>]. An evolutionary perspective indicates that variation in virulence across clones should be shaped by the costs and benefits of virulence for parasite transmission [<xref ref-type="bibr" rid="CR87">87</xref>]. The spread and persistence of virulence mutations may be favored if they covary with transmission. However, since host mortality can interrupt transmission, a range of values of virulence may lead to equivalent levels of overall fitness for the parasite [<xref ref-type="bibr" rid="CR88">88</xref>]. While it is broadly agreed that the theoretical framework and empirical evidence on the existence of virulence-transmission trade-offs need to be further developed and extended [<xref ref-type="bibr" rid="CR87">87</xref>], there are some systems where the general predictions appear to be borne out (e.g., [<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]). Perhaps most famously, the introduction of the myxoma virus into Australia was at first devastating to rabbit populations, causing near 100 % mortality. However, over subsequent years, the virulence of the infection decreased. Various lines of evidence suggest that this occurred in response to selection for increased transmission via decreased virulence &#x02013; swift rabbit mortality was not an efficient mode of transmission for the virus.</p></sec><sec id="Sec23"><title>Within-Host Dynamics</title><p>While we have so far largely discussed virus dynamics on the level of the host population, there are equally important processes to be considered on the within-host level. The &#x0201c;kinetics&#x0201d; of viral infection arise from a complex array of factors including viral replication and variability, the dynamics of the immune response, and pathogenicity to the host [<xref ref-type="bibr" rid="CR91">91</xref>]. Over the past two decades, mathematical models have played an important role in studying these dynamics, often motivated by the need to understand the actual and potential impact of interventions such as treatment or immunization [<xref ref-type="bibr" rid="CR91">91</xref>&#x02013;<xref ref-type="bibr" rid="CR93">93</xref>].</p><p>A major example is HIV infection (see 10.1007/978-1-4899-7448-8_43); its clinical course is characterized by an initial acute phase of viral replication, lasting on the order of weeks, followed by an asymptomatic latent phase that can last decades before ultimately progressing to AIDS [<xref ref-type="bibr" rid="CR94">94</xref>]. Major advances in the 1990s showed that despite the long clinical timescale involved, in vivo HIV replication is in fact a rapid process, with the viral life cycle being on the order of days [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. Subsequent studies modeling the dynamics of drug resistance underlined the need for early and aggressive drug therapy [<xref ref-type="bibr" rid="CR97">97</xref>]. Conversely, more recent work capturing the dynamics of the immune response has illustrated how immunity raised by CD8+ T-cell vaccination elicits a response that is too weak and too late to achieve sterilizing immunity [<xref ref-type="bibr" rid="CR98">98</xref>].</p><p>Hepatitis C virus (HCV) represents another major public health challenge and, like HIV, is a rapidly mutating virus capable of continually evading immunity to establish chronic infection [<xref ref-type="bibr" rid="CR99">99</xref>]. HCV infection is currently treated with broad-spectrum combination antiviral therapy including interferon-alpha, ribavirin, and protease inhibitors, with upwards of 50 % of treated patients being responders; however, there is a need for a more rationally optimized approach. Models capturing viral dynamics in treated and untreated patients have contributed to an understanding of the action of these therapies [<xref ref-type="bibr" rid="CR100">100</xref>&#x02013;<xref ref-type="bibr" rid="CR102">102</xref>], estimates of parameters such as rates of viral growth and of viral RNA clearance [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>], and correlates of long-term response to therapy [<xref ref-type="bibr" rid="CR104">104</xref>].</p><p>Modeling approaches have been used to study the kinetics of acute infections too, notably in the context of influenza infection [<xref ref-type="bibr" rid="CR105">105</xref>]. A key interest, for example, has been the relative importance of target cell depletion, innate immunity, and adaptive immunity in shaping the dynamics of viral infection [<xref ref-type="bibr" rid="CR106">106</xref>&#x02013;<xref ref-type="bibr" rid="CR108">108</xref>].</p><p>Overall, while there remain significant gaps in our understanding of these and other major viral infections [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR109">109</xref>], this work demonstrates the clinically relevant insights that can be derived from a careful study of within-host dynamics [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR110">110</xref>].</p></sec><sec id="Sec24"><title>Summary and Future Directions</title><p>This chapter has broadly outlined the multitude of factors shaping viral dynamics, as well as the role of mathematical approaches in elucidating these factors and their interactions. This growing body of work sets the stage for future directions.</p><p>The link between epidemiological modeling and policy is long-standing. Bernoulli&#x02019;s work provides perhaps the earliest case study [<xref ref-type="bibr" rid="CR1">1</xref>]; recent high-profile examples include the use of models to guide responses to foot and mouth disease in the UK [<xref ref-type="bibr" rid="CR111">111</xref>], smallpox [<xref ref-type="bibr" rid="CR112">112</xref>], and influenza [<xref ref-type="bibr" rid="CR113">113</xref>]. The key criterion of the effective deployment of models for policy is that they are embedded in testable hypotheses, embodying the best possible science. Continuing progress in this area thus calls for better understanding of the basic principles.</p><p>Especially in the context of viral evolution, whether in relation to immune escape or virulence, a complete biological framework calls for a linkage of processes across disparate scales, from the macroscopic structure of the host population to the molecular basis of viral replication and transmission. A key task at the heart of this challenge is arguably to quantify transmission potential in terms of immune escape, that is, to measure empirically how changes at the molecular level impact <italic>R</italic> (see Sect. <xref rid="Sec19" ref-type="sec">6.1</xref>). Indeed, recent equine influenza experiments provide some important steps in this direction [<xref ref-type="bibr" rid="CR114">114</xref>].</p><p>New and emerging ways of tracking disease may also help to shed new light on the global spread of viruses and on how they may be better controlled. To name three examples, while disease surveillance continues to operate largely through public health channels, there is increasing interest in the use of alternative sources, including automated tracking of Internet and social media trends [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. Second, genetic sequencing and analysis complements existing epidemiological approaches. The advent of high-throughput whole-genome sequencing is expected to shed new light on within-host viral diversity [<xref ref-type="bibr" rid="CR117">117</xref>], an important aspect in our understanding of viral evolution. Third, any viral infection leaves its mark on the host immune system. Serological studies thus offer another valuable source of information in monitoring diseases [<xref ref-type="bibr" rid="CR32">32</xref>] and already play an important role in many national surveillance programs (see 10.1007/978-1-4899-7448-8_4). While in some cases there remain challenges in the clinical interpretation of quantitative serological data (e.g., Ref. [<xref ref-type="bibr" rid="CR118">118</xref>]), its future use in estimating, for example, the prevalence of subclinical, but infectious, cases could be of significant value to public health efforts [<xref ref-type="bibr" rid="CR119">119</xref>&#x02013;<xref ref-type="bibr" rid="CR121">121</xref>].</p><p>Finally, it is important to consider the role of the hosts themselves. With the host population providing the medium through which viruses spread, important factors in viral dynamics include heterogeneities among individuals (e.g., host genetic variation [<xref ref-type="bibr" rid="CR122">122</xref>] and &#x0201c;superspreaders&#x0201d; of infection [<xref ref-type="bibr" rid="CR123">123</xref>]) and patterns of human connectivity and mobility. Various approaches are beginning to unravel some of these patterns, both in the developed [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR124">124</xref>] and in the developing world [<xref ref-type="bibr" rid="CR125">125</xref>]. Future developments in such techniques will provide valuable new data for understanding the human role in viral dynamics.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Bernoulli D. Essai d&#x02019;une nouvelle analyse de la mortalit&#x000e9; caus&#x000e9;e par la petite v&#x000e9;role et des advantages de l&#x02019;inoculation pour la pr&#x000e9;venir. M&#x000e9;m Math Phys Acad Roy Sci Paris. 1760;1&#x02013;45.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjornstad</surname><given-names>ON</given-names></name><name><surname>Finkenstadt</surname><given-names>BF</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Dynamics of measles epidemics: estimating scaling of transmission rates using a time series SIR model</article-title><source>Ecol Monogr</source><year>2002</year><volume>72</volume><fpage>169</fpage><lpage>84</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenfell</surname><given-names>BT</given-names></name><name><surname>Bjornstad</surname><given-names>ON</given-names></name><name><surname>Finkenstadt</surname><given-names>BF</given-names></name></person-group><article-title>Dynamics of measles epidemics: scaling noise, determinism, and predictability with the TSIR model</article-title><source>Ecol Monogr</source><year>2002</year><volume>72</volume><fpage>185</fpage><lpage>202</lpage></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>May</surname><given-names>RM</given-names></name></person-group><source>Infectious diseases of humans: dynamics and control</source><year>1992</year><publisher-loc>Oxford/New York</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Keeling</surname><given-names>MJ</given-names></name><name><surname>Rohani</surname><given-names>P</given-names></name></person-group><source>Modeling infectious diseases in humans and animals</source><year>2007</year><publisher-loc>Princeton</publisher-loc><publisher-name>Princeton University Press</publisher-name></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Irving</surname><given-names>WL</given-names></name><name><surname>McCauley</surname><given-names>JW</given-names></name><name><surname>Rowlands</surname><given-names>DJ</given-names></name></person-group><article-title>Dynamics and epidemiological impact of microparasites</article-title><source>New challenges to health: the threat of virus infection</source><year>2001</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Cambridge University Press</publisher-name><fpage>33</fpage><lpage>52</lpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tait</surname><given-names>DR</given-names></name><name><surname>Ward</surname><given-names>KN</given-names></name><name><surname>Brown</surname><given-names>DWG</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name></person-group><article-title>Measles and rubella misdiagnosed in infants as Exanthem subitum (roseola infantum)</article-title><source>Br Med J</source><year>1996</year><volume>312</volume><fpage>101</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">8555893</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kermack</surname><given-names>WO</given-names></name><name><surname>McKendrick</surname><given-names>AG</given-names></name></person-group><article-title>A contribution to the mathematical theory of epidemics</article-title><source>Proc R Soc London Ser A</source><year>1927</year><volume>115</volume><fpage>700</fpage><lpage>21</lpage></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>MS</given-names></name></person-group><article-title>Measles periodicity and community size</article-title><source>J R Stat Soc Ser A</source><year>1957</year><volume>120</volume><fpage>48</fpage><lpage>70</lpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>PEM</given-names></name><name><surname>Clarkson</surname><given-names>JA</given-names></name></person-group><article-title>Measles in England and Wales-I: an analysis of factors underlying seasonal patterns</article-title><source>Int J Epidemiol</source><year>1982</year><volume>11</volume><fpage>5</fpage><lpage>15</lpage><?supplied-pmid 7085179?><pub-id pub-id-type="pmid">7085179</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dietz</surname><given-names>K</given-names></name><name><surname>Schenzle</surname><given-names>D</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Atkinson</surname><given-names>AC</given-names></name><name><surname>Feinberg</surname><given-names>SE</given-names></name></person-group><article-title>Mathematical models for infectious disease statistics</article-title><source>A celebration of statistics</source><year>1985</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>167</fpage><lpage>204</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenzle</surname><given-names>D</given-names></name></person-group><article-title>An age-structured model of pre- and post-vaccination measles transmission</article-title><source>IMA J Math Appl Med Biol</source><year>1984</year><volume>1</volume><fpage>169</fpage><lpage>91</lpage><?supplied-pmid 6600102?><pub-id pub-id-type="pmid">6600102</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rand</surname><given-names>DA</given-names></name><name><surname>Wilson</surname><given-names>H</given-names></name></person-group><article-title>Chaotic stochasticity: a ubiquitous source of unpredictability in epidemics</article-title><source>Proc R Soc Lond Ser B-Biol Sci</source><year>1991</year><volume>246</volume><fpage>179</fpage><lpage>84</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Black</surname><given-names>FL</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Evans</surname><given-names>AS</given-names></name></person-group><article-title>Measles</article-title><source>Viral infections of humans: epidemiology and control</source><year>1984</year><publisher-loc>New York</publisher-loc><publisher-name>Plenum</publisher-name><fpage>397</fpage><lpage>418</lpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnett</surname><given-names>GP</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>The epidemiology of varicella zoster virus-infections &#x02013; a mathematical model</article-title><source>Epidemiol Infect</source><year>1992</year><volume>108</volume><fpage>495</fpage><lpage>511</lpage><?supplied-pmid 1318218?><pub-id pub-id-type="pmid">1318218</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavine</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>AA</given-names></name><name><surname>Bjornstad</surname><given-names>ON</given-names></name></person-group><article-title>Natural immune boosting in pertussis dynamics: the potential for long-term vaccine failure</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>7259</fpage><lpage>64</lpage><?supplied-pmid 21422281?><pub-id pub-id-type="pmid">21422281</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lessler</surname><given-names>J</given-names></name><name><surname>Metcalf</surname><given-names>CJE</given-names></name><name><surname>Grais</surname><given-names>RF</given-names></name><name><surname>Luquero</surname><given-names>FJ</given-names></name><name><surname>Cummings</surname><given-names>DAT</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis</article-title><source>PLoS Med</source><year>2011</year><volume>8</volume><fpage>ARTN e1001110</fpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>PEM</given-names></name></person-group><article-title>Herd-immunity &#x02013; history, theory, practice</article-title><source>Epidemiol Rev</source><year>1993</year><volume>15</volume><fpage>265</fpage><lpage>302</lpage><?supplied-pmid 8174658?><pub-id pub-id-type="pmid">8174658</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Fenner F, Henderson DA, Arita I, Je&#x0017e;ek Z, Ladnyi ID. Smallpox and its eradication. History of International Public Health No. 6. Geneva: World Health Organization; 1988. p. 1473.</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenfell</surname><given-names>BT</given-names></name><name><surname>Bolker</surname><given-names>BM</given-names></name></person-group><article-title>Cities and villages: infection hierarchies in a measles metapopulation</article-title><source>Ecol Lett</source><year>1998</year><volume>1</volume><fpage>63</fpage><lpage>70</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>PEM</given-names></name><name><surname>Clarkson</surname><given-names>JA</given-names></name></person-group><article-title>Seasonal influences on pertussis</article-title><source>Int J Epidemiol</source><year>1986</year><volume>15</volume><fpage>237</fpage><lpage>47</lpage><?supplied-pmid 3721687?><pub-id pub-id-type="pmid">3721687</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>D</given-names></name><name><surname>McKane</surname><given-names>AJ</given-names></name><name><surname>Pascual</surname><given-names>M</given-names></name></person-group><article-title>Stochastic amplification in epidemics</article-title><source>J R Soc Interface</source><year>2007</year><volume>4</volume><fpage>575</fpage><lpage>82</lpage><?supplied-pmid 17251128?><pub-id pub-id-type="pmid">17251128</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>MS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Neyman</surname><given-names>J</given-names></name></person-group><article-title>Deterministic and stochastic models for recurrent epidemics</article-title><source>Proceeding of the third Berkely symposium on mathematical statistics and probability</source><year>1956</year><publisher-loc>Berkeley</publisher-loc><publisher-name>University of California Press</publisher-name><fpage>81</fpage><lpage>109</lpage></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earn</surname><given-names>DJD</given-names></name><name><surname>Rohani</surname><given-names>P</given-names></name><name><surname>Bolker</surname><given-names>BM</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>A simple model for complex dynamical transitions in epidemics</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>667</fpage><lpage>70</lpage><?supplied-pmid 10650003?><pub-id pub-id-type="pmid">10650003</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenfell</surname><given-names>BT</given-names></name><name><surname>Kleczkowski</surname><given-names>A</given-names></name><name><surname>Ellner</surname><given-names>SP</given-names></name><name><surname>Bolker</surname><given-names>BM</given-names></name></person-group><article-title>Measles as a case-study in nonlinear forecasting and chaos</article-title><source>Philos Trans R Soc A</source><year>1994</year><volume>348</volume><fpage>515</fpage><lpage>30</lpage></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>MJ</given-names></name><name><surname>Grais</surname><given-names>RF</given-names></name><name><surname>Bharti</surname><given-names>N</given-names></name><etal/></person-group><article-title>The dynamics of measles in sub-Saharan Africa</article-title><source>Nature</source><year>2008</year><volume>451</volume><fpage>679</fpage><lpage>84</lpage><?supplied-pmid 18256664?><pub-id pub-id-type="pmid">18256664</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mclean</surname><given-names>AR</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name></person-group><article-title>Measles in developing countries. Part II. The predicted impact of mass vaccination</article-title><source>Epidemiol Infect</source><year>1988</year><volume>100</volume><fpage>419</fpage><lpage>42</lpage><?supplied-pmid 3378585?><pub-id pub-id-type="pmid">3378585</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrington</surname><given-names>CP</given-names></name><name><surname>Whitaker</surname><given-names>HJ</given-names></name></person-group><article-title>Contact surface models for infectious diseases: estimation from serologic survey data</article-title><source>J Am Stat Assoc</source><year>2005</year><volume>100</volume><fpage>370</fpage><lpage>9</lpage></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitaker</surname><given-names>HJ</given-names></name><name><surname>Farrington</surname><given-names>CP</given-names></name></person-group><article-title>Estimation of infectious disease parameters from serological survey data: the impact of regular epidemics</article-title><source>Stat Med</source><year>2004</year><volume>23</volume><fpage>2429</fpage><lpage>43</lpage><?supplied-pmid 15273957?><pub-id pub-id-type="pmid">15273957</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Teunis</surname><given-names>P</given-names></name><name><surname>Kretzschmar</surname><given-names>M</given-names></name></person-group><article-title>Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents</article-title><source>Am J Epidemiol</source><year>2006</year><volume>164</volume><fpage>936</fpage><lpage>44</lpage><?supplied-pmid 16968863?><pub-id pub-id-type="pmid">16968863</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmunds</surname><given-names>WJ</given-names></name><name><surname>Gay</surname><given-names>NJ</given-names></name><name><surname>Kretzschmar</surname><given-names>M</given-names></name><name><surname>Wachmann</surname><given-names>CH</given-names></name></person-group><article-title>The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies</article-title><source>Epidemiol Infect</source><year>2000</year><volume>125</volume><fpage>635</fpage><lpage>50</lpage><?supplied-pmid 11218214?><pub-id pub-id-type="pmid">11218214</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>NJ</given-names></name><name><surname>Hesketh</surname><given-names>LM</given-names></name><name><surname>Morgan-Capner</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name></person-group><article-title>Interpretation of serological surveillance data for measles using mathematical-models &#x02013; implications for vaccine strategy</article-title><source>Epidemiol Infect</source><year>1995</year><volume>115</volume><fpage>139</fpage><lpage>56</lpage><?supplied-pmid 7641827?><pub-id pub-id-type="pmid">7641827</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>DA</given-names></name></person-group><article-title>A catalytic model of infection for measles</article-title><source>Appl Stat</source><year>1974</year><volume>23</volume><fpage>330</fpage><lpage>9</lpage></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossong</surname><given-names>J</given-names></name><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Jit</surname><given-names>M</given-names></name><etal/></person-group><article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title><source>PLoS Med</source><year>2008</year><volume>5</volume><fpage>381</fpage><lpage>91</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohani</surname><given-names>P</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>King</surname><given-names>AA</given-names></name></person-group><article-title>Contact network structure explains the changing epidemiology of pertussis</article-title><source>Science</source><year>2010</year><volume>330</volume><fpage>982</fpage><lpage>5</lpage><?supplied-pmid 21071671?><pub-id pub-id-type="pmid">21071671</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>MJ</given-names></name><name><surname>Djibo</surname><given-names>A</given-names></name><name><surname>Grais</surname><given-names>RF</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name><name><surname>Bjornstad</surname><given-names>ON</given-names></name></person-group><article-title>Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example</article-title><source>Epidemiol Infect</source><year>2010</year><volume>138</volume><fpage>108</fpage><lpage>16</lpage><?supplied-pmid 19538818?><pub-id pub-id-type="pmid">19538818</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Bansal S, Pourbohloul B, Hupert N, Grenfell BT, Meyers LA. The shifting demographic landscape of pandemic influenza. PLoS One. 2010;5:ARTN e9360.</mixed-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>LZ</given-names></name></person-group><article-title>The history and medical consequences of rubella</article-title><source>Rev Infect Dis</source><year>1985</year><volume>7</volume><issue>Suppl 1</issue><fpage>S2</fpage><lpage>10</lpage><?supplied-pmid 3890105?><pub-id pub-id-type="pmid">3890105</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>CJE</given-names></name><name><surname>Lessler</surname><given-names>J</given-names></name><name><surname>Klepac</surname><given-names>P</given-names></name><name><surname>Cutts</surname><given-names>F</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination</article-title><source>Epidemiol Infect</source><year>2012</year><volume>16</volume><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>MS</given-names></name></person-group><article-title>The critical community size for measles in the U.S</article-title><source>J R Stat Soc Ser A</source><year>1960</year><volume>123</volume><fpage>37</fpage><lpage>44</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>FL</given-names></name></person-group><article-title>Measles endemicity in insular populations: critical community size and its evolutionary implication</article-title><source>J Theor Biol</source><year>1966</year><volume>11</volume><fpage>207</fpage><lpage>11</lpage><?supplied-pmid 5965486?><pub-id pub-id-type="pmid">5965486</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjornstad</surname><given-names>ON</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Hazards, spatial transmission and timing of outbreaks in epidemic metapopulations</article-title><source>Environ Ecol Stat</source><year>2008</year><volume>15</volume><fpage>265</fpage><lpage>77</lpage></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>YC</given-names></name><name><surname>Bjornstad</surname><given-names>ON</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Measles metapopulation dynamics: a gravity model for epidemiological coupling and dynamics</article-title><source>Am Nat</source><year>2004</year><volume>164</volume><fpage>267</fpage><lpage>81</lpage><?supplied-pmid 15278849?><pub-id pub-id-type="pmid">15278849</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Lucey</surname><given-names>B</given-names></name><name><surname>Waller</surname><given-names>LA</given-names></name><name><surname>Childs</surname><given-names>JE</given-names></name><name><surname>Real</surname><given-names>LA</given-names></name></person-group><article-title>Predicting the spatial dynamics of rabies epidemics on heterogeneous landscapes</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>3668</fpage><lpage>772</lpage><?supplied-pmid 11904426?><pub-id pub-id-type="pmid">11904426</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Viboud C, Miller MA, Grenfell BT, Bjornstad ON, Simonsen L. Air travel and the spread of influenza: Important caveats (vol 3, pg 0, 2007). Plos Med. 2007;4:198-198-ARTN e32.</mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitzer</surname><given-names>VE</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name><name><surname>Simonsen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>290</fpage><lpage>4</lpage><?supplied-pmid 19608910?><pub-id pub-id-type="pmid">19608910</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Grenfell B, Harwood J. (Meta) population dynamics of infectious diseases. Trends Ecol Evol. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0169534797011749">http://www.sciencedirect.com/science/article/pii/S0169534797011749</ext-link>.</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>May</surname><given-names>RM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Hallam</surname><given-names>TG</given-names></name><name><surname>Levin</surname><given-names>SA</given-names></name></person-group><article-title>Population biology of microparasitic infections</article-title><source>Biomathematics</source><year>1986</year><publisher-loc>Berlin</publisher-loc><publisher-name>Springer</publisher-name><fpage>405</fpage><lpage>42</lpage></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogra</surname><given-names>PL</given-names></name></person-group><article-title>Respiratory syncytial virus: the virus, the disease and the immune response</article-title><source>Paediatr Respir Rev</source><year>2004</year><volume>5</volume><issue>Suppl A</issue><fpage>S119</fpage><lpage>26</lpage><?supplied-pmid 14980256?><pub-id pub-id-type="pmid">14980256</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>EF</given-names></name><name><surname>Lindesmith</surname><given-names>LC</given-names></name><name><surname>Lobue</surname><given-names>AD</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name></person-group><article-title>Viral shape-shifting: norovirus evasion of the human immune system</article-title><source>Nat Rev Microbiol</source><year>2010</year><volume>8</volume><fpage>231</fpage><lpage>41</lpage><?supplied-pmid 20125087?><pub-id pub-id-type="pmid">20125087</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>RM</given-names></name><name><surname>Fitch</surname><given-names>WM</given-names></name><name><surname>Bender</surname><given-names>CA</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name></person-group><article-title>Positive selection on the H3 hemagglutinin gene of human influenza virus A</article-title><source>Mol Biol Evol</source><year>1999</year><volume>16</volume><fpage>1457</fpage><lpage>65</lpage><?supplied-pmid 10555276?><pub-id pub-id-type="pmid">10555276</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dushoff</surname><given-names>J</given-names></name><name><surname>Plotkin</surname><given-names>JB</given-names></name><name><surname>Levin</surname><given-names>SA</given-names></name><name><surname>Earn</surname><given-names>DJ</given-names></name></person-group><article-title>Dynamical resonance can account for seasonality of influenza epidemics</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>16915</fpage><lpage>6</lpage><?supplied-pmid 15557003?><pub-id pub-id-type="pmid">15557003</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladstone</surname><given-names>BP</given-names></name><name><surname>Ramani</surname><given-names>S</given-names></name><name><surname>Mukhopadhya</surname><given-names>I</given-names></name><etal/></person-group><article-title>Protective effect of natural rotavirus infection in an Indian birth cohort</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>337</fpage><lpage>46</lpage><?supplied-pmid 21793745?><pub-id pub-id-type="pmid">21793745</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velazquez</surname><given-names>FR</given-names></name><name><surname>Matson</surname><given-names>DO</given-names></name><name><surname>Calva</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Rotavirus infections in infants as protection against subsequent infections</article-title><source>N Engl J Med</source><year>1996</year><volume>335</volume><fpage>1022</fpage><lpage>8</lpage><?supplied-pmid 8793926?><pub-id pub-id-type="pmid">8793926</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boots</surname><given-names>M</given-names></name><name><surname>Greenman</surname><given-names>J</given-names></name><name><surname>Ross</surname><given-names>D</given-names></name><name><surname>Norman</surname><given-names>R</given-names></name><name><surname>Hails</surname><given-names>R</given-names></name><name><surname>Sait</surname><given-names>S</given-names></name></person-group><article-title>The population dynamical implications of covert infections in host-microparasite interactions</article-title><source>J Anim Ecol</source><year>2003</year><volume>72</volume><fpage>1064</fpage><lpage>72</lpage></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>Garnett</surname><given-names>GP</given-names></name></person-group><article-title>Mass vaccination to control chickenpox: the influence of zoster</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>7231</fpage><lpage>5</lpage><?supplied-pmid 8692974?><pub-id pub-id-type="pmid">8692974</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>MG</given-names></name><name><surname>Halstead</surname><given-names>SB</given-names></name><name><surname>Artsob</surname><given-names>H</given-names></name><etal/></person-group><article-title>Dengue: a continuing global threat</article-title><source>Nat Rev Microbiol</source><year>2010</year><volume>8</volume><fpage>S7</fpage><lpage>16</lpage><?supplied-pmid 21079655?><pub-id pub-id-type="pmid">21079655</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenfell</surname><given-names>BT</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name><name><surname>Gog</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Unifying the epidemiological and evolutionary dynamics of pathogens</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>327</fpage><lpage>32</lpage><?supplied-pmid 14726583?><pub-id pub-id-type="pmid">14726583</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">van Nimwegen (2006) Influenza escapes immunity along neutral networks. Science. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.sciencemag.org/content/314/5807/1884.full">http://www.sciencemag.org/content/314/5807/1884.full</ext-link>.</mixed-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>RR</given-names></name><name><surname>Juffrie</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>R</given-names></name><etal/></person-group><article-title>A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. Studies in 1995-1996</article-title><source>Am J Trop Med Hyg</source><year>1999</year><volume>61</volume><fpage>412</fpage><lpage>9</lpage><?supplied-pmid 10497982?><pub-id pub-id-type="pmid">10497982</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kliks</surname><given-names>SC</given-names></name><name><surname>Nimmanitya</surname><given-names>S</given-names></name><name><surname>Nisalak</surname><given-names>A</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name></person-group><article-title>Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants</article-title><source>Am J Trop Med Hyg</source><year>1988</year><volume>38</volume><fpage>411</fpage><lpage>9</lpage><?supplied-pmid 3354774?><pub-id pub-id-type="pmid">3354774</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sangkawibha</surname><given-names>N</given-names></name><name><surname>Rojanasuphot</surname><given-names>S</given-names></name><name><surname>Ahandrik</surname><given-names>S</given-names></name><etal/></person-group><article-title>Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak</article-title><source>Am J Epidemiol</source><year>1984</year><volume>120</volume><fpage>653</fpage><lpage>69</lpage><?supplied-pmid 6496446?><pub-id pub-id-type="pmid">6496446</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalvez</surname><given-names>AP</given-names></name><name><surname>Engle</surname><given-names>RE</given-names></name><name><surname>St Claire</surname><given-names>M</given-names></name><name><surname>Purcell</surname><given-names>RH</given-names></name><name><surname>Lai</surname><given-names>CJ</given-names></name></person-group><article-title>Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>9422</fpage><lpage>7</lpage><?supplied-pmid 17517625?><pub-id pub-id-type="pmid">17517625</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halstead</surname><given-names>SB</given-names></name></person-group><article-title>Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade</article-title><source>Rev Infect Dis</source><year>1989</year><volume>11</volume><issue>Suppl 4</issue><fpage>S830</fpage><lpage>9</lpage><?supplied-pmid 2665015?><pub-id pub-id-type="pmid">2665015</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menalorca</surname><given-names>J</given-names></name><name><surname>Hethcote</surname><given-names>HW</given-names></name></person-group><article-title>Dynamic models of infectious-diseases as regulators of population sizes</article-title><source>J Math Biol</source><year>1992</year><volume>30</volume><fpage>693</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">1522392</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recker</surname><given-names>M</given-names></name><name><surname>Blyuss</surname><given-names>KB</given-names></name><name><surname>Simmons</surname><given-names>CP</given-names></name><etal/></person-group><article-title>Immunological serotype interactions and their effect on the epidemiological pattern of dengue</article-title><source>Proc R Soc B</source><year>2009</year><volume>276</volume><fpage>2541</fpage><lpage>8</lpage><?supplied-pmid 19369266?><pub-id pub-id-type="pmid">19369266</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name></person-group><article-title>The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>790</fpage><lpage>4</lpage><?supplied-pmid 9892712?><pub-id pub-id-type="pmid">9892712</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>AB</given-names></name></person-group><article-title>Research on dengue during World War II</article-title><source>Am J Trop Med Hyg</source><year>1952</year><volume>1</volume><fpage>30</fpage><lpage>50</lpage><?supplied-pmid 14903434?><pub-id pub-id-type="pmid">14903434</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>B</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>14234</fpage><lpage>9</lpage><?supplied-pmid 16966609?><pub-id pub-id-type="pmid">16966609</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wearing</surname><given-names>HJ</given-names></name><name><surname>Rohani</surname><given-names>P</given-names></name></person-group><article-title>Ecological and immunological determinants of dengue epidemics</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>11802</fpage><lpage>7</lpage><?supplied-pmid 16868086?><pub-id pub-id-type="pmid">16868086</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagao</surname><given-names>Y</given-names></name><name><surname>Koelle</surname><given-names>K</given-names></name></person-group><article-title>Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><fpage>2238</fpage><lpage>43</lpage><?supplied-pmid 18250338?><pub-id pub-id-type="pmid">18250338</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>EC</given-names></name></person-group><source>The evolution and emergence of RNA viruses</source><year>2009</year><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name><fpage>272</fpage></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korber</surname><given-names>BT</given-names></name><name><surname>Allen</surname><given-names>EE</given-names></name><name><surname>Farmer</surname><given-names>AD</given-names></name><name><surname>Myers</surname><given-names>GL</given-names></name></person-group><article-title>Heterogeneity of HIV-1 and HIV-2</article-title><source>AIDS</source><year>1995</year><volume>9</volume><issue>Suppl A</issue><fpage>S5</fpage><lpage>18</lpage><?supplied-pmid 8819565?><pub-id pub-id-type="pmid">8819565</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>DJ</given-names></name><name><surname>Lapedes</surname><given-names>AS</given-names></name><name><surname>de Jong</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Mapping the antigenic and genetic evolution of influenza virus</article-title><source>Science</source><year>2004</year><volume>305</volume><fpage>371</fpage><lpage>6</lpage><?supplied-pmid 15218094?><pub-id pub-id-type="pmid">15218094</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Laver</surname><given-names>WG</given-names></name><name><surname>Air</surname><given-names>GM</given-names></name><name><surname>Schild</surname><given-names>GC</given-names></name></person-group><article-title>Molecular mechanisms of variation in influenza viruses</article-title><source>Nature</source><year>1982</year><volume>296</volume><fpage>115</fpage><lpage>21</lpage><?supplied-pmid 6174870?><pub-id pub-id-type="pmid">6174870</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensley</surname><given-names>SE</given-names></name><name><surname>Das</surname><given-names>SR</given-names></name><name><surname>Bailey</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>734</fpage><lpage>6</lpage><?supplied-pmid 19900932?><pub-id pub-id-type="pmid">19900932</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>IT</given-names></name></person-group><article-title>Effects of glycosylation on the properties and functions of influenza virus hemagglutinin</article-title><source>J Infect Dis</source><year>1997</year><volume>176</volume><issue>Suppl 1</issue><fpage>S24</fpage><lpage>8</lpage><?supplied-pmid 9240690?><pub-id pub-id-type="pmid">9240690</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigerust</surname><given-names>DJ</given-names></name><name><surname>Ulett</surname><given-names>KB</given-names></name><name><surname>Boyd</surname><given-names>KL</given-names></name><name><surname>Madsen</surname><given-names>J</given-names></name><name><surname>Hawgood</surname><given-names>S</given-names></name><name><surname>McCullers</surname><given-names>JA</given-names></name></person-group><article-title>N-linked glycosylation attenuates H3N2 influenza viruses</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>8593</fpage><lpage>600</lpage><?supplied-pmid 17553891?><pub-id pub-id-type="pmid">17553891</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="other">Arinaminpathy N, Grenfell B. Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS One. 2010;5:ARTN e15674.</mixed-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburne</surname><given-names>BP</given-names></name><name><surname>Hay</surname><given-names>AJ</given-names></name><name><surname>Goldstein</surname><given-names>RA</given-names></name></person-group><article-title>Changing selective pressure during antigenic changes in human influenza H3</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000058</fpage><?supplied-pmid 18451985?><pub-id pub-id-type="pmid">18451985</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrat</surname><given-names>F</given-names></name><name><surname>Flahault</surname><given-names>A</given-names></name></person-group><article-title>Influenza vaccine: the challenge of antigenic drift</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>6852</fpage><lpage>62</lpage><?supplied-pmid 17719149?><pub-id pub-id-type="pmid">17719149</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koelle</surname><given-names>K</given-names></name><name><surname>Cobey</surname><given-names>S</given-names></name><name><surname>Grenfell</surname><given-names>B</given-names></name><name><surname>Pascual</surname><given-names>M</given-names></name></person-group><article-title>Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>1898</fpage><lpage>903</lpage><?supplied-pmid 17185596?><pub-id pub-id-type="pmid">17185596</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Galvani</surname><given-names>AP</given-names></name><name><surname>Bush</surname><given-names>RM</given-names></name></person-group><article-title>Ecological and immunological determinants of influenza evolution</article-title><source>Nature</source><year>2003</year><volume>422</volume><fpage>428</fpage><lpage>33</lpage><?supplied-pmid 12660783?><pub-id pub-id-type="pmid">12660783</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M</given-names></name></person-group><article-title>Evolutionary rate at the molecular level</article-title><source>Nature</source><year>1968</year><volume>217</volume><fpage>624</fpage><lpage>6</lpage><?supplied-pmid 5637732?><pub-id pub-id-type="pmid">5637732</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recker</surname><given-names>M</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name><name><surname>Nee</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name></person-group><article-title>The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>7711</fpage><lpage>6</lpage><?supplied-pmid 17460037?><pub-id pub-id-type="pmid">17460037</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>EC</given-names></name><name><surname>Burch</surname><given-names>SS</given-names></name></person-group><article-title>The causes and consequences of genetic variation in dengue virus</article-title><source>Trends Microbiol</source><year>2000</year><volume>8</volume><fpage>74</fpage><lpage>7</lpage><?supplied-pmid 10664600?><pub-id pub-id-type="pmid">10664600</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizon</surname><given-names>S</given-names></name><name><surname>Hurford</surname><given-names>A</given-names></name><name><surname>Mideo</surname><given-names>N</given-names></name><name><surname>Van Baalen</surname><given-names>M</given-names></name></person-group><article-title>Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future</article-title><source>J Evol Biol</source><year>2009</year><volume>22</volume><fpage>245</fpage><lpage>59</lpage><?supplied-pmid 19196383?><pub-id pub-id-type="pmid">19196383</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>RM</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name></person-group><article-title>Parasite-host coevolution</article-title><source>Parasitology</source><year>1990</year><volume>100</volume><issue>Suppl</issue><fpage>S89</fpage><lpage>101</lpage><?supplied-pmid 2122393?><pub-id pub-id-type="pmid">2122393</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Hollingsworth</surname><given-names>TD</given-names></name><name><surname>Chapman</surname><given-names>R</given-names></name><name><surname>de Wolf</surname><given-names>F</given-names></name><name><surname>Hanage</surname><given-names>WP</given-names></name></person-group><article-title>Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>17441</fpage><lpage>6</lpage><?supplied-pmid 17954909?><pub-id pub-id-type="pmid">17954909</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenner</surname><given-names>F</given-names></name><name><surname>Day</surname><given-names>MF</given-names></name><name><surname>Woodroofe</surname><given-names>GM</given-names></name></person-group><article-title>The epidemiological consequences of the mechanical transmission of myxomatosis by mosquitoes</article-title><source>J Hygiene</source><year>1956</year><volume>54</volume><fpage>284</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">13346086</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perelson</surname><given-names>AS</given-names></name></person-group><article-title>Modelling viral and immune system dynamics</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>28</fpage><lpage>36</lpage><?supplied-pmid 11905835?><pub-id pub-id-type="pmid">11905835</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antia</surname><given-names>R</given-names></name><name><surname>Ganusov</surname><given-names>VV</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><article-title>The role of models in understanding CD8+ T-cell memory</article-title><source>Nat Rev Immunol</source><year>2005</year><volume>5</volume><fpage>101</fpage><lpage>11</lpage><?supplied-pmid 15662368?><pub-id pub-id-type="pmid">15662368</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regoes</surname><given-names>RR</given-names></name><name><surname>Yates</surname><given-names>A</given-names></name><name><surname>Antia</surname><given-names>R</given-names></name></person-group><article-title>Mathematical models of cytotoxic T-lymphocyte killing</article-title><source>Immunol Cell Biol</source><year>2007</year><volume>85</volume><fpage>274</fpage><lpage>9</lpage><?supplied-pmid 17420769?><pub-id pub-id-type="pmid">17420769</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>The human immunodeficiency virus: infectivity and mechanisms of pathogenesis</article-title><source>Science</source><year>1988</year><volume>239</volume><fpage>617</fpage><lpage>22</lpage><?supplied-pmid 3277274?><pub-id pub-id-type="pmid">3277274</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perelson</surname><given-names>AS</given-names></name><name><surname>Neumann</surname><given-names>AU</given-names></name><name><surname>Markowitz</surname><given-names>M</given-names></name><name><surname>Leonard</surname><given-names>JM</given-names></name><name><surname>Ho</surname><given-names>DD</given-names></name></person-group><article-title>HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time</article-title><source>Science</source><year>1996</year><volume>271</volume><fpage>1582</fpage><lpage>6</lpage><?supplied-pmid 8599114?><pub-id pub-id-type="pmid">8599114</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Ghosh</surname><given-names>SK</given-names></name><name><surname>Taylor</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Viral dynamics in human immunodeficiency virus type 1 infection</article-title><source>Nature</source><year>1995</year><volume>373</volume><fpage>117</fpage><lpage>22</lpage><?supplied-pmid 7529365?><pub-id pub-id-type="pmid">7529365</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonhoeffer</surname><given-names>S</given-names></name><name><surname>May</surname><given-names>RM</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Nowak</surname><given-names>MA</given-names></name></person-group><article-title>Virus dynamics and drug therapy</article-title><source>Proc Natl Acad Sci U S A</source><year>1997</year><volume>94</volume><fpage>6971</fpage><lpage>6</lpage><?supplied-pmid 9192676?><pub-id pub-id-type="pmid">9192676</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Boer</surname><given-names>RJ</given-names></name></person-group><article-title>Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>2838</fpage><lpage>48</lpage><?supplied-pmid 17202215?><pub-id pub-id-type="pmid">17202215</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauer</surname><given-names>GM</given-names></name><name><surname>Walker</surname><given-names>BD</given-names></name></person-group><article-title>Hepatitis C virus infection</article-title><source>N Engl J Med</source><year>2001</year><volume>345</volume><fpage>41</fpage><lpage>52</lpage><?supplied-pmid 11439948?><pub-id pub-id-type="pmid">11439948</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>NM</given-names></name><name><surname>Layden-Almer</surname><given-names>JE</given-names></name><name><surname>Layden</surname><given-names>TJ</given-names></name><name><surname>Perelson</surname><given-names>AS</given-names></name></person-group><article-title>Modelling how ribavirin improves interferon response rates in hepatitis C virus infection</article-title><source>Nature</source><year>2004</year><volume>432</volume><fpage>922</fpage><lpage>4</lpage><?supplied-pmid 15602565?><pub-id pub-id-type="pmid">15602565</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Marinos</surname><given-names>G</given-names></name><name><surname>Modi</surname><given-names>M</given-names></name><name><surname>Zeuzem</surname><given-names>S</given-names></name></person-group><article-title>Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon</article-title><source>Hepatology</source><year>2003</year><volume>37</volume><fpage>1351</fpage><lpage>8</lpage><?supplied-pmid 12774014?><pub-id pub-id-type="pmid">12774014</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>AU</given-names></name><name><surname>Lam</surname><given-names>NP</given-names></name><name><surname>Dahari</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy</article-title><source>Science</source><year>1998</year><volume>282</volume><fpage>103</fpage><lpage>7</lpage><?supplied-pmid 9756471?><pub-id pub-id-type="pmid">9756471</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perelson</surname><given-names>AS</given-names></name><name><surname>Herrmann</surname><given-names>E</given-names></name><name><surname>Micol</surname><given-names>F</given-names></name><name><surname>Zeuzem</surname><given-names>S</given-names></name></person-group><article-title>New kinetic models for the hepatitis C virus</article-title><source>Hepatology</source><year>2005</year><volume>42</volume><fpage>749</fpage><lpage>54</lpage><?supplied-pmid 16175615?><pub-id pub-id-type="pmid">16175615</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeuzem</surname><given-names>S</given-names></name></person-group><article-title>The kinetics of hepatitis C virus infection</article-title><source>Clin Liver Dis</source><year>2001</year><volume>5</volume><fpage>917</fpage><lpage>30</lpage><?supplied-pmid 11685801?><pub-id pub-id-type="pmid">11685801</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beauchemin</surname><given-names>CA</given-names></name><name><surname>Handel</surname><given-names>A</given-names></name></person-group><article-title>A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead</article-title><source>BMC Public Health</source><year>2011</year><volume>11</volume><issue>Suppl 1</issue><fpage>S7</fpage><?supplied-pmid 21356136?><pub-id pub-id-type="pmid">21356136</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saenz</surname><given-names>RA</given-names></name><name><surname>Quinlivan</surname><given-names>M</given-names></name><name><surname>Elton</surname><given-names>D</given-names></name><etal/></person-group><article-title>Dynamics of influenza virus infection and pathology</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>3974</fpage><lpage>83</lpage><?supplied-pmid 20130053?><pub-id pub-id-type="pmid">20130053</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baccam</surname><given-names>P</given-names></name><name><surname>Beauchemin</surname><given-names>C</given-names></name><name><surname>Macken</surname><given-names>CA</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Perelson</surname><given-names>AS</given-names></name></person-group><article-title>Kinetics of influenza A virus infection in humans</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>7590</fpage><lpage>9</lpage><?supplied-pmid 16840338?><pub-id pub-id-type="pmid">16840338</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handel</surname><given-names>A</given-names></name><name><surname>Longini</surname><given-names>IMJ</given-names></name><name><surname>Antia</surname><given-names>R</given-names></name></person-group><article-title>Towards a quantitative understanding of the within-host dynamics of influenza A infections</article-title><source>J R Soc Interface</source><year>2010</year><volume>7</volume><fpage>35</fpage><lpage>47</lpage><?supplied-pmid 19474085?><pub-id pub-id-type="pmid">19474085</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname><given-names>MP</given-names></name><name><surname>Ribeiro</surname><given-names>RM</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>DP</given-names></name><name><surname>Perelson</surname><given-names>AS</given-names></name></person-group><article-title>Understanding the mechanisms and limitations of immune control of HIV</article-title><source>Immunol Rev</source><year>2007</year><volume>216</volume><fpage>164</fpage><lpage>75</lpage><?supplied-pmid 17367342?><pub-id pub-id-type="pmid">17367342</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeuzem</surname><given-names>S</given-names></name></person-group><article-title>Clinical implications of hepatitis C viral kinetics</article-title><source>J Hepatol</source><year>1999</year><volume>31</volume><issue>Suppl 1</issue><fpage>61</fpage><lpage>4</lpage><?supplied-pmid 10622562?><pub-id pub-id-type="pmid">10622562</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keeling</surname><given-names>MJ</given-names></name><name><surname>Woolhouse</surname><given-names>MEJ</given-names></name><name><surname>Shaw</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>813</fpage><lpage>7</lpage><?supplied-pmid 11679661?><pub-id pub-id-type="pmid">11679661</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Keeling</surname><given-names>MJ</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Planning for smallpox outbreaks</article-title><source>Nature</source><year>2003</year><volume>425</volume><fpage>681</fpage><lpage>5</lpage><?supplied-pmid 14562094?><pub-id pub-id-type="pmid">14562094</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Cummings</surname><given-names>DAT</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Cajka</surname><given-names>JC</given-names></name><name><surname>Cooley</surname><given-names>PC</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name></person-group><article-title>Strategies for mitigating an influenza pandemic</article-title><source>Nature</source><year>2006</year><volume>442</volume><fpage>448</fpage><lpage>52</lpage><?supplied-pmid 16642006?><pub-id pub-id-type="pmid">16642006</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>AW</given-names></name><name><surname>Daly</surname><given-names>JM</given-names></name><name><surname>Lewis</surname><given-names>NS</given-names></name><name><surname>Smith</surname><given-names>DJ</given-names></name><name><surname>Wood</surname><given-names>JLN</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Quantifying the impact of immune escape on transmission dynamics of influenza</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>726</fpage><lpage>8</lpage><?supplied-pmid 19900931?><pub-id pub-id-type="pmid">19900931</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="other">Salathe M, Khandelwal S. Assessing vaccination sentiments with online social media: implications for infectious disease dynamics and control. Plos Comput Biol. 2011;7:ARTN e1002199.</mixed-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Blench</surname><given-names>M</given-names></name><name><surname>Tolentino</surname><given-names>H</given-names></name><etal/></person-group><article-title>Use of unstructured event-based reports for global infectious disease surveillance</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>689</fpage><lpage>95</lpage><?supplied-pmid 19402953?><pub-id pub-id-type="pmid">19402953</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beerenwinkel</surname><given-names>N</given-names></name><name><surname>Zagordi</surname><given-names>O</given-names></name></person-group><article-title>Ultra-deep sequencing for the analysis of viral populations</article-title><source>Curr Opin Virol</source><year>2011</year><volume>1</volume><fpage>413</fpage><lpage>8</lpage><?supplied-pmid 22440844?><pub-id pub-id-type="pmid">22440844</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuano</surname><given-names>AW</given-names></name><name><surname>Dawson</surname><given-names>JD</given-names></name><name><surname>Gray</surname><given-names>GC</given-names></name></person-group><article-title>Maximizing power in seroepidemiological studies through the use of the proportional odds model</article-title><source>Influenza Other Respi Viruses</source><year>2007</year><volume>1</volume><fpage>87</fpage><lpage>93</lpage></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>Deeks</surname><given-names>SL</given-names></name><name><surname>Hatchette</surname><given-names>TF</given-names></name><name><surname>Crowcroft</surname><given-names>NS</given-names></name></person-group><article-title>The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases</article-title><source>CMAJ</source><year>2012</year><volume>184</volume><fpage>E70</fpage><lpage>6</lpage><?supplied-pmid 22083674?><pub-id pub-id-type="pmid">22083674</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malkin</surname><given-names>JE</given-names></name></person-group><article-title>Epidemiology of genital herpes simplex virus infection in developed countries</article-title><source>Herpes</source><year>2004</year><volume>11</volume><issue>Suppl 1</issue><fpage>2A</fpage><lpage>23</lpage><?supplied-pmid 15115626?><pub-id pub-id-type="pmid">15115626</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>DY</given-names></name><name><surname>Cheng</surname><given-names>KF</given-names></name><name><surname>Li</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e14555</fpage><?supplied-pmid 21267441?><pub-id pub-id-type="pmid">21267441</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>L</given-names></name><name><surname>Prentice</surname><given-names>HA</given-names></name><name><surname>Farmer</surname><given-names>P</given-names></name><etal/></person-group><article-title>Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>708</fpage><lpage>15</lpage><?supplied-pmid 23115285?><pub-id pub-id-type="pmid">23115285</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Schreiber</surname><given-names>SJ</given-names></name><name><surname>Kopp</surname><given-names>PE</given-names></name><name><surname>Getz</surname><given-names>WM</given-names></name></person-group><article-title>Superspreading and the effect of individual variation on disease emergence</article-title><source>Nature</source><year>2005</year><volume>438</volume><issue>7066</issue><fpage>355</fpage><lpage>9</lpage><?supplied-pmid 16292310?><pub-id pub-id-type="pmid">16292310</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>MC</given-names></name><name><surname>Hidalgo</surname><given-names>CA</given-names></name><name><surname>Barabasi</surname><given-names>AL</given-names></name></person-group><article-title>Understanding individual human mobility patterns</article-title><source>Nature</source><year>2008</year><volume>453</volume><issue>7196</issue><fpage>779</fpage><lpage>82</lpage><?supplied-pmid 18528393?><pub-id pub-id-type="pmid">18528393</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharti</surname><given-names>N</given-names></name><name><surname>Tatem</surname><given-names>AJ</given-names></name><name><surname>Ferrari</surname><given-names>MJ</given-names></name><name><surname>Grais</surname><given-names>RF</given-names></name><name><surname>Djibo</surname><given-names>A</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery</article-title><source>Science</source><year>2011</year><volume>334</volume><fpage>1424</fpage><lpage>7</lpage><?supplied-pmid 22158822?><pub-id pub-id-type="pmid">22158822</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="other">Finkenst&#x000e4;dt BF, Grenfell BT. Time series modelling of childhood diseases: a dynamical systems approach. J.Royal Society Series C (Applied Statistics). 2000;49(2):187&#x02013;205.</mixed-citation></ref></ref-list></back></article>